Customer Event Tashkent
Meet. Connect. Discover.
25 April 2024
Venue: Hyatt Regency
1 A, Navoi Avenue, Tashkent, Uzbekistan
Agenda
- 08:00–09:00 - Sign-in and welcome
- 09:00–09:30 - Keynotes
- 09:30–14:30 - Session 1- Pharmacopoeia quality standards and current regulatory issues
- 14:30–17:00 - Session 2 - Determination of Impurities in Pharmaceuticals: Why and How?
- 17:00–17:30 - Closing remarks
08:00–09:00 - Sign-in and welcome
09:00–09:30 - Keynotes
- Venkat Surendra Nath Koduru, Senior Vice President, Regions & Program Operations USP
- Alessandro Slama, Vice President, Regions & Program Operations USP
- Agzam Nartaev, Director, Center for Pharmaceutical Products Safety
09:30–14:30 - Session 1: Pharmacopoeia quality standards and current regulatory issues
| Time | Topic | Speaker |
| 09:30–10:00 | Perspectives of Localization of Pharmaceutical Manufacturing | Abdulla Abdisalamovich Azizov, Director of the Pharmaceutical Industry Development Agency |
| 10:00–10:30 | Medicines We Can Trust: USP Impact | Stefano D’Amico, USP Strategic Customer Development Manager EMEA |
| 10:30–11:00 | USP Comprehensive Solutions Helps To Mitigate Risks To Pharmaceutical Quality and Accelerate Product Development | Amanda Guiraldelli, USP Scientific Affairs Manager EMEA |
| 11:00–11:15 | Break | |
| 11:15–11:45 | Current issues of development and implementation in practice of the State Pharmacopoeia of the Republic of Uzbekistan | Khabibulla Jalilov, Head of Pharmacopeia Development Dept, CPPS |
| 11:45–12:00 | Post-Marketing Surveillance: the shared responsibility of the manufacturer with public health | Gulnora Zufarova, Advisor to the Director, CPPS |
| 12:00–12:15 | Pharmacovigilance | Elvira Svechnikova, Head of Pharmacovigilance Dept., CPPS |
| 12:15–12:30 | Registration Process for Medicines and Medical Devices | Mukaramoy Ergashova, Head of Laboratory of pharmaco-toxicological analysis |
| 12:30–13:00 | Q&A with speakers | |
| 13:00–14:00 | Lunch | |
| 14:00–14:30 | Flexibility approach and the possibility of its application in the development of pharmacopeial standards | Ardak Tulegenova, Head of the Department for the Improvement of the SPh of Kazakhstan |
Moderated by: Foreign Pharma Association of Uzbekistan
14:30–17:00: Session 2 - Determination of Impurities in Pharmaceuticals: Why and How?
| Time | Topic | Speaker |
| 14:30– 15:00 | USP’s Perspective on Impurities Control in Pharmaceuticals | Amanda Guiraldelli, USP Scientific Affairs Manager EMEA |
| 15:00– 15:30 | Impurities in excipients: USP Tools and Regulatory Focus | Christian Zeine, USP Senior Scientific Affairs Manager EMEA |
| 15:30– 16:00 | Measures to prevent adverse events related to contamination of medicines with EG and DEG in Uzbekistan | Khurshid Tursunov, Laboratory of Medicines Quality Control and Standardization, CPPS |
| 16:00– 16:15 | Break | |
| 16:15– 16:45 | Validation, Transfer and Verification of Analytical Procedures: Enable Accurate, Reproducible Results While Streamlining Your Analyses | Amanda Guiraldelli, USP Scientific Affairs Manager EMEA |
| 16:45– 17:00 | Q&A |
Moderated by: Stefano D’Amico, USP Strategic Customer Development Manager EMEA
17:00–17:30: Closing remarks
- Venkat Surendra Nath Koduru, Senior Vice-President for Regional and Programme Activities, USP
- Alessandro Slama, Vice President, Regions & Program Operations USP
- Agzam Nartaev, Director, Center for Pharmaceutical Products Safety
Note: Agenda is subject to change. If there are any changes, we will announce them via email.